CDP Equity acquires 23.5% stake in Angelini Pharma for €1bn
CDP Equity acquires 23.5% stake in Angelini Pharma for €1bn
CDP Equity acquires 23.5% stake in Angelini Pharma for €1bn
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.